Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04151784 · ClinicalTrials.gov registry record

Factors That Impact the Relationship Between Pulmonary Status and Susceptibility to Electronic Cigarette Use

A clinical trial, sponsored by University of Alabama at Birmingham.

Completed
Registry status
200
Enrollment target

NCT04151784: Completed study, sponsored by University of Alabama at Birmingham.

NCT04151784 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04151784 has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
200 participants
Enrollment target

Study Summary

The purpose of the study is to explores various psycho-social, physiological, cognitive, behavioral, and environmental factors that may affect the association between pulmonary status and Susceptibility to Electronic Cigarette Use

Primary Outcome

The DASS-21 is a clinical assessment that measures the state of depression, It has 21 questions. The internal consistency of the DASS-21 scales was acceptable (depression: alpha = .829). The scale range is from 0 to 28 + with 0 being closest to normal and 28+ being extremely severe. The DASS-21 is a clinical assessment that measures the state of anxiety, It has 21 questions. The internal consistency of the DASS-21 scales was acceptable (anxiety : alpha = .778). The scale range is from 0 to 20 +

Interventions

  • OTHER Pulmonary Group
  • OTHER Healthy Control

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2020-01-01
Est. Completion 2021-05-20
University of Alabama at Birmingham

1,160 total trials

What the finished NCT04151784 record still lists

NCT04151784 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Pulmonary Group is the first listed.

NCT04151784 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04151784 about?

NCT04151784 is a clinical study titled "Factors That Impact the Relationship Between Pulmonary Status and Susceptibility to Electronic Cigarette Use". The purpose of the study is to explores various psycho-social, physiological, cognitive, behavioral, and environmental factors that may affect the association between pulmonary status and Susceptibility to Electronic Cigarette Use

What is the current status of trial NCT04151784?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2020-01-01. Estimated completion is 2021-05-20.

What interventions are being tested in trial NCT04151784?

The interventions under investigation include: Pulmonary Group (OTHER), Healthy Control (OTHER).

Who is sponsoring clinical trial NCT04151784?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04151784, the US trial registry maintained by the National Library of Medicine. NCT04151784 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.